hydroxyindoleacetic acid has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (51.28) | 18.7374 |
1990's | 16 (41.03) | 18.2507 |
2000's | 2 (5.13) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (2.56) | 2.80 |
Authors | Studies |
---|---|
Aigner, TG; Cohen, RM; Doudet, DJ; McLellan, CA | 1 |
Wesemann, W | 1 |
Calne, DB; Fibiger, HC; Guttman, M; Jakubovic, A | 1 |
Bankiewicz, KS; Hsiao, J; Mefford, I; Skirboll, S; Wang, J | 1 |
Mizutani, N; Nagatsu, T; Naoi, M; Ochi, N; Ohya, Y; Watanabe, K | 1 |
Chan, WW; Rausch, WD; Riederer, P; Schallauer, E; Weiser, M | 1 |
Benítez, J; Casarejos, MJ; García de Yébenes, J; García de Yébenes, MJ; García-Agundez, JA; Jiménez-Jiménez, FJ; Martínez, A; Mena, MA; Pardo, B; Tabernero, C | 1 |
Gerlach, M; Mihatsch, W; Przuntek, H; Riederer, P; Russ, H | 1 |
Bonuccelli, U; Fariello, R; Garant, D | 1 |
Henning, K; Pindur, U; Przuntek, H; Russ, H | 1 |
Carlsson, A; Clark, D; Fornstedt, B; Pileblad, E | 1 |
Bradbury, AJ; Costall, B; Domeney, AM; Jenner, PG; Marsden, CD; Naylor, RJ; Testa, B | 1 |
Fuller, RW; Hemrick-Luecke, SK; Robertson, DW | 1 |
Bradbury, AJ; Costall, B; Domeney, AM; Jenner, PJ; Marsden, CD; Naylor, RJ | 1 |
Bédard, P; Boucher, R; Daigle, M; Di Paolo, T | 1 |
DeMattei, M; Fariello, RG; Ferraro, TN; Golden, GT; Hare, TA | 1 |
Bacon, JP; Hanselman, DS; Johannessen, JN; Markey, CJ; Markey, SP; Savitt, JM; Weisz, A | 1 |
Bonuccelli, U; Corsini, GU; Kopin, IJ; Schinelli, S; Zuddas, A | 1 |
Audsley, AR; Sirinathsinghji, DJ; Whittington, PE | 1 |
Arai, Y; Kinemuchi, H; Kisara, K; Matsumura, T; Sakuma, I; Satoh, N; Tadano, T | 1 |
Arora, PK; Blue, P; Harik, SI; Iacofano, LA; Sayre, LM; Schmidley, JW | 1 |
Sheng, JG; Tang, QM; Xu, DL; Xu, XR; Yu, HZ | 1 |
Fukuda, H; Hara, K; Kameyama, M; Kimura, H; Nakamura, S | 1 |
Burns, RS; Ebert, MH; Kopin, IJ; LeWitt, PA; Pakkenberg, H | 1 |
Eckhardt, H; Henning, K; Przuntek, H; Russ, H | 1 |
Collins, MA; Neafsey, EJ | 1 |
Carlsson, A; Nissbrandt, H; Pileblad, E | 1 |
Burns, RS; Chiueh, CC; Ebert, MH; Jacobowitz, DM; Kopin, IJ; Markey, SP | 1 |
Burns, RS; Chiueh, CC; Johannessen, JN; Kopin, IJ; Markey, SP; Pert, A | 1 |
Fuller, RW; Hemrick-Luecke, SK; Snoddy, HD | 1 |
Gupta, M; Wiener, HL | 1 |
Alessandri, MG; Corsini, GU; Fornai, F; Saginario, A; Vaglini, F | 1 |
Block, F; Clement, HW; Grote, C; Sontag, KH; Wesemann, W | 1 |
Gerlach, M; Przuntek, H; Riederer, P; Russ, H; Stasch, JP; Traber, J; Winker, J; Witzmann, K | 1 |
Altagracia, M; Kravzov, J; Rios, C; Rojas, P | 1 |
Donovan, DM; Kirstein, CL; Kostic, V; Miner, LL; Perry, MP; Philpot, RM; Przedborski, S; Revay, RS; Rothman, RB; Schindler, CW; Sharpe, LG; Uhl, GR | 1 |
Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T | 1 |
Andrews, AM; Mazzola-Pomietto, P; Murphy, DL; Unger, EL | 1 |
He, L; Huang, H; Shi, J; Xie, S; Yang, R; Yang, Y; Ye, S; Zhang, S; Zhang, Y | 1 |
39 other study(ies) available for hydroxyindoleacetic acid and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbidopa; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary; Receptors, Dopamine; Tomography, Emission-Computed | 1992 |
Therapy of Morbus Parkinson and radical-induced neurotoxicity in the rat--in vivo voltammetric studies.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Apomorphine; Corpus Striatum; Dopamine; Electrochemistry; Free Radicals; Haloperidol; Hydroxyindoleacetic Acid; Male; Memantine; Neurotoxins; Parkinson Disease; Rats; Rats, Wistar; Rotenone; Serotonin; Substantia Nigra | 1992 |
Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain; Carotid Arteries; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intra-Arterial; Macaca fascicularis; Male; Osmolar Concentration; Parkinson Disease; Serotonin; Tissue Distribution | 1990 |
In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Caudate Nucleus; Dialysis; Dopamine; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Male; Parkinson Disease, Secondary; Putamen | 1990 |
Transplacentally-transported 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects the catecholamine and indoleamine levels in the fetal mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Chemistry; Dopamine; Female; Hydroxyindoleacetic Acid; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Pregnancy; Serotonin | 1990 |
Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Amantadine; Animals; Caudate Nucleus; Corpus Striatum; Dopamine; Drug Interactions; Female; Gerbillinae; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Parkinson Disease, Secondary; Selegiline; Serotonin | 1990 |
Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a model of rat designated a poor metabolizer of debrisoquine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Dark Adaptation; Debrisoquin; Female; Hydroxyindoleacetic Acid; Motor Activity; Norepinephrine; Rats; Rats, Inbred F344; Rats, Inbred Strains; Serotonin; Time Factors | 1991 |
Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain; Callitrichinae; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Administration Schedule; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Motor Activity; MPTP Poisoning; Norepinephrine; Parkinson Disease; Posture; Serotonin; Substantia Nigra | 1991 |
The acute convulsant effect of MPTP is dependent on intracerebral MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Convulsants; Corpus Striatum; Ditiocarb; Drug Interactions; Epilepsy; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; MPTP Poisoning; Status Epilepticus; Stereotyped Behavior | 1991 |
The protective effect of 1-tert.butyl-4,4-diphenylpiperidine against the nigrostriatal neurodegeneration caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Drug Interactions; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Piperidines; Pyridines; Rats; Rats, Inbred Strains; Serotonin | 1985 |
Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 5-Hydroxytryptophan; Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Pyridines; Rats; Rats, Inbred Strains; Species Specificity; Time Factors; Tryptophan; Tyrosine | 1985 |
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Diseases; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Movement Disorders; Norepinephrine; Pyridines; Pyridinium Compounds; Rats; Serotonin; Substantia Nigra | 1985 |
Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Biogenic Amines; Brain Chemistry; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; p-Chloroamphetamine; Pyridines; Rats; Rats, Inbred Strains; Serotonin; Time Factors | 1985 |
The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Homovanillic Acid; Hydroxydopamines; Hydroxyindoleacetic Acid; Male; Movement Disorders; Neurotransmitter Agents; Oxidopamine; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Substantia Nigra | 1986 |
Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain; Bromocriptine; Catecholamines; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Macaca fascicularis; Parkinson Disease, Secondary; Prolactin; Pyridines | 1986 |
Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Extrapyramidal Tracts; Glutathione; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Pyridines; Substantia Nigra | 1986 |
The development of amine substituted analogues of MPTP as unique tools for the study of MPTP toxicity and Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Amines; Animals; Brain Chemistry; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Immunologic Techniques; Male; Mice; Pargyline; Parkinson Disease, Secondary; Pyridines; Serotonin; Structure-Activity Relationship | 1987 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Acetaldehyde; Animals; Brain; Dopamine; Drug Synergism; Ethanol; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; Neurotoxins; Pyridines; Serotonin | 1987 |
Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Caudate Nucleus; Dopamine; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine; Pyridines; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra | 1986 |
Behavioral and biochemical changes following acute administration of MPTP and MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Desipramine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Motor Activity; Nomifensine; Pyridines; Pyridinium Compounds; Selegiline; Serotonin | 1987 |
On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Histocytochemistry; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Neurons; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra | 1987 |
Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Basal Ganglia Diseases; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; MSH Release-Inhibiting Hormone; Norepinephrine; Pyridines; Serotonin; Substantia Nigra | 1987 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) enhances tryptophan hydroxylase activity in mouse striatum, but not in the frontal cortex.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cerebral Cortex; Corpus Striatum; Dopamine; Hydroxyindoleacetic Acid; Kinetics; Male; Mice; Mice, Inbred ICR; Organ Specificity; Pyridines; Reference Values; Serotonin; Tryptophan Hydroxylase | 1988 |
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Substance-Related Disorders; Substantia Nigra; Syndrome | 1985 |
The influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the levels of dopamine, serotonin and their metabolites in the caudate nucleus of the rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Disease Models, Animal; Dopamine; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Parkinson Disease, Secondary; Pyridines; Rats; Rats, Inbred Strains; Serotonin | 1985 |
Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Aotus trivirgatus; Carbolines; Caudate Nucleus; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Indoles; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Serotonin; Substantia Nigra | 1985 |
Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Motor Activity; Pyridines; Serotonin | 1984 |
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Disease Models, Animal; Dopamine; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Macaca mulatta; Male; Neurons; Parkinson Disease; Posture; Pyridines; Substantia Nigra | 1983 |
Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Caudate Nucleus; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Nucleus Accumbens; Pyridines; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra | 1984 |
Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antidepressive Agents; Biogenic Monoamines; Brain; Dopamine; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Norepinephrine; Oxidopamine; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes | 1994 |
Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Corpus Striatum; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neurotransmitter Agents; Olfactory Pathways; Selegiline | 1995 |
beta,beta'-Iminodipropionitrile-induced persistent dyskinetic syndrome in mice is transiently modified by MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Biogenic Monoamines; Cerebral Cortex; Corpus Striatum; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Homovanillic Acid; Hydroxyindoleacetic Acid; Mice; Mice, Inbred C57BL; Neural Pathways; Nitriles; Rats; Rats, Sprague-Dawley; Species Specificity | 1993 |
Functional studies on monoaminergic transmitter release in parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Apomorphine; Biogenic Monoamines; Dopamine; Dopamine Agents; Dopamine Antagonists; Hydroxyindoleacetic Acid; Levodopa; Male; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Rats; Rats, Wistar; Stereotyped Behavior; Tryptophan | 1993 |
Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Caudate Nucleus; Dopamine; Dopamine Agents; Homovanillic Acid; Hydroxyindoleacetic Acid; Mice; Mice, Inbred C57BL; Nimodipine; Serotonin | 1993 |
Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Brain Chemistry; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Parkinson Disease, Secondary; Probenecid; Serotonin | 1993 |
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Carrier Proteins; Chromatography, High Pressure Liquid; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Gene Expression Regulation; Genetic Variation; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred Strains; Mice, Transgenic; Motor Activity; MPTP Poisoning; Nerve Tissue Proteins; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; Reward; Serotonin; Substantia Nigra; Transgenes; Tyrosine 3-Monooxygenase | 1999 |
Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Drug Administration Schedule; Homovanillic Acid; Hydroxyindoleacetic Acid; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Parkinson Disease; Parkinson Disease, Secondary; Serotonin; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 2001 |
2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Body Temperature; Brain Chemistry; Carrier Proteins; Hydroxyindoleacetic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2002 |
Serotonin and dopamine depletion in distinct brain regions may cause anxiety in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice as a model of early Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anxiety; Corpus Striatum; Disease Models, Animal; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; Parkinson Disease; Pyrrolidines; Serotonin | 2023 |